Advisor Group Holdings, Inc. Kinnate Biopharma Inc. Transaction History

Advisor Group Holdings, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$3.46 - $7.98 $4,152 - $9,576	1,200 New	1,200 $7,000
Q2 2022 Aug 10, 2022	SELL	$7.43 - $13.0 $193 - $338	-26 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$7.73 - $17.99 $200 - $467	26 New	26 $0

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.